Page 1 | Search Results | Blood | American Society of Hematology

1-13 of 13

Sort by

Sort Order Select

Journal Articles

Clustering of Bleeding Symptoms in Patients Previously Diagnosed As Type 3 Von Willebrand Disease: Results from a Large Cohort of Type 3 Von Willebrand Disease (the 3Winters-Ips Project)

Blood (2018) 132 (Supplement 1): 2465.

https://doi.org/10.1182/blood-2018-99-113996

Published: 2018

Journal Articles

Profile of Mutations Identified in the 3WINTERS-IPS Project on European & Iranian Patients with Previously Diagnosed Type 3 Von Willebrand Disease.

Luciano Baronciani, PhD, Flora Peyvandi, MD PhD, Anne Goodeve, PhD, Reinhard Schneppenheim, MDPhD, Zahra Badiee, Mohammad-Reza Baghaipour, Javier Battle, Erik Berntorp, MD PhD, Imre Bodó, MD PhD, Ulrich Budde, MD, Andrea Cairo, PhD, Giancarlo Castaman, Laura Crookes, Jeroen C.J. Eikenboom, MD, Peyman Eshghi, MD, Cosimo Ettorre, MD, Jenny Goudemand, MD PhD, Wolf Hassenpflug, Charles Richard Morris Hay, MDFRCP,FRCPath, Hamid Hoorfar, MD, Mehran Karimi, MD, Bijan Keikhaei, Riitta Lassila, MD PR, Frank W.G. Leebeek, MD PhD, Maria Fernanda Lopez Fernandez, Pier Mannuccio Mannucci, MD, Maria Gabriella Mazzucconi, MD, Massimo Morfini, MD, Nikolas Nikšić, Johannes Oldenburg, Florian Oyen, Rafael Parra Lòpez, Ian Peake, PhD, Gholamreza Toogeh, Alberto Tosetto, Marc Trossaert, Sayed Omid Reza Zekavat, MD, Eva M.K. Zetterberg, MD PhD, Augusto B Federici, MD

Blood (2018) 132 (Supplement 1): 1184.

https://doi.org/10.1182/blood-2018-99-114702

Published: 2018

Journal Articles

Identification of Novel Mutations with Molecular Modelling of Missense Mutations of Congenital Afibrinogenemia Patients in Pakistan

Tehmina nafees sonia Khan, M.B;B.S ,PhD, Arshi Naz, MSc.PhD, Arjit Biswas, Anne Goodeve, PhD, Nisar Ahmed, FCPS haematology, Shariq Ahmed, B.S, Tahir Shamsi, MBBS, MRCPath,FRCPath, Johannes Oldenburg

Blood (2015) 126 (23): 4664.

https://doi.org/10.1182/blood.V126.23.4664.4664

Published: 2015

Journal Articles

Characterization and Expression of an In-Frame Exon 33-34 Deletion Causing Type 1 VWD

Ashley Cartwright, PhD, Pamela A Christopherson, Crystal L. Perry, Sandra L Haberichter, PhD, Daniel Hampshire, PhD, Ian R. Peake, PhD, Anne Goodeve, PhD, Robert R Montgomery, MD, Daniel B. Bellissimo, the Zimmerman Program Investigators

Blood (2014) 124 (21): 1525.

https://doi.org/10.1182/blood.V124.21.1525.1525

Published: 2014

Journal Articles

VWF propeptide and ratios between VWF, VWF propeptide, and FVIII in the characterization of type 1 von Willebrand disease

Jeroen Eikenboom, Augusto B. Federici, Richard J. Dirven, Giancarlo Castaman, Francesco Rodeghiero, Ulrich Budde, Reinhard Schneppenheim, Javier Batlle, Maria Teresa Canciani, Jenny Goudemand, Ian Peake, Anne Goodeve, the MCMDM-1VWD Study Group

Blood (2013) 121 (12): 2336–2339.

https://doi.org/10.1182/blood-2012-09-455089

Published: 2013

Includes: Supplemental data

Journal Articles

Identification of type 1 von Willebrand disease patients with reduced von Willebrand factor survival by assay of the VWF propeptide in the European study: Molecular and Clinical Markers for the Diagnosis and Management of Type 1 VWD (MCMDM-1VWD)

Blood (2008) 111 (10): 4979–4985.

https://doi.org/10.1182/blood-2007-09-110940

Published: 2008

Journal Articles

Response to desmopressin is influenced by the genotype and phenotype in type 1 von Willebrand disease (VWD): results from the European Study MCMDM-1VWD

Blood (2008) 111 (7): 3531–3539.

https://doi.org/10.1182/blood-2007-08-109231

Published: 2008

Includes: Supplemental data

Journal Articles

Investigation of Underlying Reasons of Factor VIII Deficiency in Haemophilia A Patients with Undetectable Mutations in the Factor VIII Gene.

Osman El-Maarri, Jörg Schröder, Claudia Klein, Rainer Schwaab, PD., Dr., Anne Goodeve, Claude Negrier, Arthur Thompson, Alok Srivastava, Johannes Oldenburg

Blood (2006) 108 (11): 1042.

https://doi.org/10.1182/blood.V108.11.1042.1042

Published: 2006

Journal Articles

Phenotype and genotype of a cohort of families historically diagnosed with type 1 von Willebrand disease in the European study, Molecular and Clinical Markers for the Diagnosis and Management of Type 1 von Willebrand Disease (MCMDM-1VWD)

Blood (2006) 109 (1): 112–121.

https://doi.org/10.1182/blood-2006-05-020784

Published: 2006

Includes: Supplemental data

Journal Articles

Comparison of Phenotypic Assessment and Mutation Detection in the Diagnosis of Carrier State in Hemophilia: Identification of 10 Novel Mutations.

Ampaiwan Chuansumrit, MD, Werasak Sasanakul, BSc, Ian Williams, MD, Anne Goodeve, PhD, Praguywan Kadegasem, BSc, Ian Peake, PhD

Blood (2004) 104 (11): 4020.

https://doi.org/10.1182/blood.V104.11.4020.4020

Published: 2004

Journal Articles

Late Relapsing Childhood Lymphoblastic Leukemia

Ajay Vora, Lindsay Frost, Anne Goodeve, Gill Wilson, R.M. Ireland, John Lilleyman, Tim Eden, Ian Peake, Sue Richards

Blood (1998) 92 (7): 2334–2337.

https://doi.org/10.1182/blood.V92.7.2334

Published: 1998

Journal Articles

BCR-ABL Transcript With an e19a2 (c3a2) Junction in Classical Chronic Myeloid Leukemia

Gill Wilson, Lindsay Frost, Anne Goodeve, Elisabeth Vandenberghe, Ian Peake, John Reilly

Blood (1997) 89 (8): 3064.

https://doi.org/10.1182/blood.V89.8.3064

Published: 1997

Journal Articles

A novel DNA inversion causing severe hemophilia A

JA Naylor, P Nicholson, Anne Goodeve, S Hassock, I Peake, F Giannelli

Blood (1996) 87 (8): 3255–3261.

https://doi.org/10.1182/blood.V87.8.3255.bloodjournal8783255

Published: 1996

NARROW

Clustering of Bleeding Symptoms in Patients Previously Diagnosed As Type 3 Von Willebrand Disease: Results from a Large Cohort of Type 3 Von Willebrand Disease (the 3Winters-Ips Project)

Profile of Mutations Identified in the 3WINTERS-IPS Project on European & Iranian Patients with Previously Diagnosed Type 3 Von Willebrand Disease.

Identification of Novel Mutations with Molecular Modelling of Missense Mutations of Congenital Afibrinogenemia Patients in Pakistan

Characterization and Expression of an In-Frame Exon 33-34 Deletion Causing Type 1 VWD

VWF propeptide and ratios between VWF, VWF propeptide, and FVIII in the characterization of type 1 von Willebrand disease

Identification of type 1 von Willebrand disease patients with reduced von Willebrand factor survival by assay of the VWF propeptide in the European study: Molecular and Clinical Markers for the Diagnosis and Management of Type 1 VWD (MCMDM-1VWD)

Response to desmopressin is influenced by the genotype and phenotype in type 1 von Willebrand disease (VWD): results from the European Study MCMDM-1VWD

Investigation of Underlying Reasons of Factor VIII Deficiency in Haemophilia A Patients with Undetectable Mutations in the Factor VIII Gene.

Phenotype and genotype of a cohort of families historically diagnosed with type 1 von Willebrand disease in the European study, Molecular and Clinical Markers for the Diagnosis and Management of Type 1 von Willebrand Disease (MCMDM-1VWD)

Comparison of Phenotypic Assessment and Mutation Detection in the Diagnosis of Carrier State in Hemophilia: Identification of 10 Novel Mutations.

Late Relapsing Childhood Lymphoblastic Leukemia

BCR-ABL Transcript With an e19a2 (c3a2) Junction in Classical Chronic Myeloid Leukemia

A novel DNA inversion causing severe hemophilia A

Email alerts

ASH Publications

American Society of Hematology

Email alerts

ASH Publications

American Society of Hematology

This Feature Is Available To Subscribers Only